We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

150 hedge funds and large institutions have $2.87B invested in Legend Biotech in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more call options, than puts

Call options by funds: $47.7M | Put options by funds: $15.5M

55% more capital invested

Capital invested by funds: $1.85B → $2.87B (+$1.02B)

45% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 22

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

6% more funds holding

Funds holding: 141 → 150 (+9)

0.39% more ownership

Funds ownership: 16.7% → 17.09% (+0.39%)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

Holders
150
Holders Change
+9
Holders Change %
+6.38%
% of All Funds
2.53%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
32
Increased
50
Reduced
50
Closed
22
Calls
$47.7M
Puts
$15.5M
Net Calls
+$32.2M
Net Calls Change
+$25.8M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$179M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$32M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24M
4
ITP
Iron Triangle Partners
Connecticut
+$20.9M
5
SC
Samlyn Capital
New York
+$19.2M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$106M
2
BBA
Baker Bros. Advisors
New York
-$48.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$25.9M
4
PA
Perceptive Advisors
New York
-$22.4M
5
CII
Capital International Inc
California
-$22.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
101
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$847K +$166K +3,921 +34%
DekaBank Deutsche Girozentrale
102
DekaBank Deutsche Girozentrale
Germany
$745K +$61.6K +1,459 +12%
California State Teachers Retirement System (CalSTRS)
103
California State Teachers Retirement System (CalSTRS)
California
$730K +$561K +13,281 New
Zurich Cantonal Bank
104
Zurich Cantonal Bank
Switzerland
$664K -$433K -10,261 -46%
PAM
105
Panagora Asset Management
Massachusetts
$654K – – –
RC
106
Renaissance Capital
Connecticut
$614K +$154K +3,647 +49%
CIAS
107
Capital Investment Advisory Services
North Carolina
$613K +$471K +11,150 New
Mitsubishi UFJ Trust & Banking
108
Mitsubishi UFJ Trust & Banking
Japan
$565K -$3.21K -76 -0.7%
SAM
109
Sectoral Asset Management
Quebec, Canada
$550K -$84.5K -2,000 -17%
EAM
110
Erste Asset Management
Austria
$528K – – –
Man Group
111
Man Group
United Kingdom
$518K -$407K -9,627 Closed
Los Angeles Capital Management
112
Los Angeles Capital Management
California
$500K – – –
SAM
113
Storebrand Asset Management
Norway
$476K +$365K +8,654 New
SAM
114
Shell Asset Management
Netherlands
$418K +$321K +7,600 New
AR
115
Advisory Research
Illinois
$411K +$315K +7,471 New
SWRP
116
Summit Wealth & Retirement Planning
California
$392K +$301K +7,123 New
Asset Management One
117
Asset Management One
Japan
$383K -$476K -11,262 -62%
EAMA
118
EFG Asset Management (Americas)
Florida
$361K -$49.6K -1,175 -15%
TRCT
119
Tower Research Capital (TRC)
New York
$354K +$218K +5,160 +402%
CF
120
CNA Financial
Illinois
$353K -$154K -3,640 -36%
APG Asset Management
121
APG Asset Management
Netherlands
$316K -$203K -4,800 -44%
VPIM
122
Vanguard Personalized Indexing Management
California
$303K +$233K +5,514 New
Balyasny Asset Management
123
Balyasny Asset Management
Illinois
$303K +$233K +5,515 New
Aberdeen Group
124
Aberdeen Group
United Kingdom
$295K +$226K +5,353 New
VEA
125
Virtus ETF Advisers
New York
$290K +$87.8K +2,079 +65%
3 4
5
6 7

LEGN Hedge Fund Activity: Q2 2022 in Review

150 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q2 2022, worth a combined $2.87B — up 55% from $1.85B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new LEGN positions and 22 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was HHLR Advisors, cutting an estimated $106M.

  • 150 institutional investors held Legend Biotech (LEGN) as of Q2 2022, up from 141 in Q1 2022.
  • Funds reported $2.87B of Legend Biotech stock for Q2 2022, up 55% quarter-over-quarter.
  • 32 funds opened new Legend Biotech positions in Q2 2022 and 22 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q2 2022 was Fidelity Investments, an estimated $179M added.
  • The largest Legend Biotech seller in Q2 2022 was HHLR Advisors, an estimated $106M sold.

Based on aggregated 13F filings for Q2 2022.